ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $1.34 billion. The enterprise value is $1.13 billion.
Important Dates
The last earnings date was Wednesday, May 14, 2025, before market open.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SPRY has 98.21 million shares outstanding. The number of shares has increased by 1.62% in one year.
Current Share Class | 98.21M |
Shares Outstanding | 98.21M |
Shares Change (YoY) | +1.62% |
Shares Change (QoQ) | -17.74% |
Owned by Insiders (%) | 18.58% |
Owned by Institutions (%) | 49.62% |
Float | 47.54M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 13.63 |
Forward PS | 8.88 |
PB Ratio | 5.83 |
P/TBV Ratio | 6.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 11.63 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.00, with a Debt / Equity ratio of 0.30.
Current Ratio | 11.00 |
Quick Ratio | 10.35 |
Debt / Equity | 0.30 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6.91% and return on invested capital (ROIC) is -6.48%.
Return on Equity (ROE) | -6.91% |
Return on Assets (ROA) | -6.10% |
Return on Invested Capital (ROIC) | -6.48% |
Return on Capital Employed (ROCE) | -9.03% |
Revenue Per Employee | $607,013 |
Profits Per Employee | -$97,813 |
Employee Count | 160 |
Asset Turnover | 0.35 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, SPRY has paid $288,000 in taxes.
Income Tax | 288,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.15% in the last 52 weeks. The beta is 0.94, so SPRY's price volatility has been similar to the market average.
Beta (5Y) | 0.94 |
52-Week Price Change | +53.15% |
50-Day Moving Average | 13.20 |
200-Day Moving Average | 13.07 |
Relative Strength Index (RSI) | 51.19 |
Average Volume (20 Days) | 1,390,482 |
Short Selling Information
The latest short interest is 16.73 million, so 17.03% of the outstanding shares have been sold short.
Short Interest | 16.73M |
Short Previous Month | 16.46M |
Short % of Shares Out | 17.03% |
Short % of Float | 35.18% |
Short Ratio (days to cover) | 9.95 |
Income Statement
In the last 12 months, SPRY had revenue of $97.12 million and -$15.65 million in losses. Loss per share was -$0.16.
Revenue | 97.12M |
Gross Profit | 77.75M |
Operating Income | -27.07M |
Pretax Income | -44.84M |
Net Income | -15.65M |
EBITDA | -26.72M |
EBIT | -27.07M |
Loss Per Share | -$0.16 |
Full Income Statement Balance Sheet
The company has $275.73 million in cash and $69.46 million in debt, giving a net cash position of $206.27 million or $2.10 per share.
Cash & Cash Equivalents | 275.73M |
Total Debt | 69.46M |
Net Cash | 206.27M |
Net Cash Per Share | $2.10 |
Equity (Book Value) | 228.97M |
Book Value Per Share | 2.33 |
Working Capital | 276.24M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$20.48 million and capital expenditures -$571,000, giving a free cash flow of -$21.06 million.
Operating Cash Flow | -20.48M |
Capital Expenditures | -571,000 |
Free Cash Flow | -21.06M |
FCF Per Share | -$0.21 |
Full Cash Flow Statement Margins
Gross margin is 80.06%, with operating and profit margins of -27.87% and -16.11%.
Gross Margin | 80.06% |
Operating Margin | -27.87% |
Pretax Margin | -15.82% |
Profit Margin | -16.11% |
EBITDA Margin | -27.51% |
EBIT Margin | -27.87% |
FCF Margin | n/a |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.62% |
Shareholder Yield | -1.62% |
Earnings Yield | -1.17% |
FCF Yield | -1.58% |
Analyst Forecast
The average price target for SPRY is $28.75, which is 111.40% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $28.75 |
Price Target Difference | 111.40% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 49.99% |
EPS Growth Forecast (5Y) | 71.25% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of 7.29 and a Piotroski F-Score of 1.
Altman Z-Score | 7.29 |
Piotroski F-Score | 1 |